However, it has recently been demonstrated that a Sema4A-NRP1 specific interaction is required by Treg cells to inhibit anti-tumor immune responses and showed significant promise in therapeutic intervention in inflammatory colitis in mice [37]. Here, SEMA4A is linked to neoplasm.